Correct Answer: D. Colposcopy directed biopsy
A positive Pap smear in a symptomatic woman (post-coital bleeding) indicates cervical cytological abnormality and requires immediate histological confirmation. The next step is NOT repeat cytology or definitive surgery, but colposcopy-directed biopsy, which is the gold standard for evaluating abnormal Pap smears in India and globally. Colposcopy allows direct visualization of the cervix under magnification, identification of acetowhite areas and abnormal vascular patterns, and targeted tissue sampling from the most suspicious lesion. This achieves two goals: (1) confirms the diagnosis histologically, ruling out malignancy or identifying CIN grade, and (2) guides treatment intensity (loop excision for CIN 2/3, observation for CIN 1). Post-coital bleeding is a red flag symptom suggesting possible invasive disease, making tissue diagnosis mandatory before any surgical intervention. Per Indian guidelines (NRHM cervical cancer screening protocols) and standard gynecological practice, colposcopy-directed biopsy is the standard of care after an abnormal Pap smear, regardless of symptoms. This approach avoids both under-treatment (missing invasive cancer) and over-treatment (hysterectomy without histology).
Why the other options are wrong
A. Repeat pap smear — This is wrong because a positive Pap smear already indicates cytological abnormality and requires histological confirmation, not repeat cytology. Repeating Pap smear delays diagnosis and is inappropriate in a symptomatic patient with post-coital bleeding. Repeat cytology is only considered for borderline/ASCUS results or follow-up after treatment, not for abnormal smears. NBE may trap students who confuse Pap smear follow-up protocols with initial abnormal smear management. B. Cone biopsy — This is wrong because cone biopsy is a therapeutic procedure (excisional biopsy) used AFTER colposcopy-directed biopsy confirms CIN 2/3, not as the initial diagnostic step. Performing cone biopsy without prior colposcopy and histology risks unnecessary tissue loss and may miss areas of concern. Cone biopsy is reserved for treatment of confirmed CIN or when colposcopy is inadequate, not for initial evaluation of abnormal Pap smears. C. Hysterectomy — This is wrong because hysterectomy is a definitive surgical procedure that should never be performed without prior histological confirmation of the lesion. Performing hysterectomy on an abnormal Pap smear alone risks over-treatment and removes the uterus unnecessarily if the lesion is benign or low-grade CIN. Hysterectomy may be considered only after colposcopy-biopsy confirms invasive cancer or in specific clinical scenarios, never as initial management of abnormal cytology.
High-Yield Facts
- Abnormal Pap smear → colposcopy-directed biopsy is the standard next step for histological confirmation before any treatment.
- Colposcopy uses 10–15× magnification and acetic acid to identify acetowhite lesions and abnormal vasculature for targeted biopsy.
- Post-coital bleeding is a red flag symptom suggesting possible invasive cervical cancer, mandating tissue diagnosis urgently.
- Cone biopsy is a therapeutic excisional procedure for confirmed CIN 2/3, not an initial diagnostic tool.
- Indian cervical cancer screening (NRHM) recommends Pap smear followed by colposcopy-biopsy for abnormal results to reduce mortality in resource-limited settings.
Mnemonics
PAP → COL → BIO → TREAT Pap smear (screening) → Colposcopy (visualization) → Biopsy (diagnosis) → Treatment (based on histology). This sequence ensures no step is skipped and diagnosis precedes treatment. ABC of Abnormal Pap Abnormal Pap → Biopsy (via colposcopy) → Confirm diagnosis. Never jump to hysterectomy (D) without B.
NBE Trap
NBE may pair "positive Pap smear" with "hysterectomy" to trap students who confuse screening results with definitive treatment, or pair it with "repeat Pap" to confuse initial abnormal smear management with follow-up protocols for borderline cytology.
Clinical Pearl
In Indian outpatient gynecology, a woman with post-coital bleeding and abnormal Pap smear is at high risk for cervical cancer given delayed presentation patterns; colposcopy-directed biopsy in the same visit (or within 2 weeks) is critical to avoid diagnostic delay and ensure early intervention, which significantly improves survival in resource-limited settings.
_Reference: DC Dutta's Textbook of Gynaecology (6th ed.), Ch. 24 (Cervical Cancer); Harrison's Principles of Internal Medicine, Ch. 82 (Gynecologic Malignancies)_